These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29375304)

  • 1. Icariin Reduces Dopaminergic Neuronal Loss and Microglia-Mediated Inflammation
    Wang GQ; Li DD; Huang C; Lu DS; Zhang C; Zhou SY; Liu J; Zhang F
    Front Mol Neurosci; 2017; 10():441. PubMed ID: 29375304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icariin attenuates neuroinflammation and exerts dopamine neuroprotection via an Nrf2-dependent manner.
    Zhang B; Wang G; He J; Yang Q; Li D; Li J; Zhang F
    J Neuroinflammation; 2019 Apr; 16(1):92. PubMed ID: 31010422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrahydroxystilbene Glucoside Produces Neuroprotection against 6-OHDA-Induced Dopamine Neurotoxicity.
    Huang C; Lin F; Wang G; Lu D; Wu Q; Liu J; Shi J; Zhang F
    Oxid Med Cell Longev; 2018; 2018():7927568. PubMed ID: 29576855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naringenin Produces Neuroprotection Against LPS-Induced Dopamine Neurotoxicity via the Inhibition of Microglial NLRP3 Inflammasome Activation.
    Chen C; Wei YZ; He XM; Li DD; Wang GQ; Li JJ; Zhang F
    Front Immunol; 2019; 10():936. PubMed ID: 31118933
    [No Abstract]   [Full Text] [Related]  

  • 5. Icariin targets Nrf2 signaling to inhibit microglia-mediated neuroinflammation.
    Zheng Y; Zhu G; He J; Wang G; Li D; Zhang F
    Int Immunopharmacol; 2019 Aug; 73():304-311. PubMed ID: 31128530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Treatment of Icariin and L-DOPA Against 6-OHDA-Lesioned Dopamine Neurotoxicity.
    Lu DS; Chen C; Zheng YX; Li DD; Wang GQ; Liu J; Shi J; Zhang F
    Front Mol Neurosci; 2018; 11():155. PubMed ID: 29867347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroquercetin alleviates dopamine neuron loss via regulating TREM2 activation.
    Yang R; Li DD; Li XX; Yang XX; Gao HM; Zhang F
    Int J Biol Macromol; 2024 Jun; 269(Pt 2):132179. PubMed ID: 38723817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intraperitoneal injection of lipopolysaccharide-induced peripheral inflammation on dopamine neuron damage in rat midbrain.
    Yang QY; Li XW; Yang R; Qin TY; Long H; Zhang SB; Zhang F
    CNS Neurosci Ther; 2022 Oct; 28(10):1624-1636. PubMed ID: 35789066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions.
    Zhang F; Shi JS; Zhou H; Wilson B; Hong JS; Gao HM
    Mol Pharmacol; 2010 Sep; 78(3):466-77. PubMed ID: 20554604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual modulation on glial cells by tetrahydroxystilbene glucoside protects against dopamine neuronal loss.
    Zhou Y; Wang G; Li D; Wang Y; Wu Q; Shi J; Zhang F
    J Neuroinflammation; 2018 May; 15(1):161. PubMed ID: 29801454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
    Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms.
    Fu SP; Wang JF; Xue WJ; Liu HM; Liu BR; Zeng YL; Li SN; Huang BX; Lv QK; Wang W; Liu JX
    J Neuroinflammation; 2015 Jan; 12():9. PubMed ID: 25595674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxymatrine Attenuates Dopaminergic Neuronal Damage and Microglia-Mediated Neuroinflammation Through Cathepsin D-Dependent HMGB1/TLR4/NF-κB Pathway in Parkinson's Disease.
    Gan P; Ding L; Hang G; Xia Q; Huang Z; Ye X; Qian X
    Front Pharmacol; 2020; 11():776. PubMed ID: 32528295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ellagic Acid Protects Dopamine Neurons via Inhibition of NLRP3 Inflammasome Activation in Microglia.
    He XM; Zhou YZ; Sheng S; Li JJ; Wang GQ; Zhang F
    Oxid Med Cell Longev; 2020; 2020():2963540. PubMed ID: 33294118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis.
    Huang B; Liu J; Meng T; Li Y; He D; Ran X; Chen G; Guo W; Kan X; Fu S; Wang W; Liu D
    Front Immunol; 2018; 9():2527. PubMed ID: 30455692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
    Kim HD; Jeong KH; Jung UJ; Kim SR
    J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia.
    Bai L; Zhang X; Li X; Liu N; Lou F; Ma H; Luo X; Ren Y
    Mol Med Rep; 2015 Jul; 12(1):1002-8. PubMed ID: 25777539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity.
    Zhang D; Hu X; Wei SJ; Liu J; Gao H; Qian L; Wilson B; Liu G; Hong JS
    J Neuroinflammation; 2008 May; 5():21. PubMed ID: 18507839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower Affinity of Isradipine for L-Type Ca
    Ortner NJ; Bock G; Dougalis A; Kharitonova M; Duda J; Hess S; Tuluc P; Pomberger T; Stefanova N; Pitterl F; Ciossek T; Oberacher H; Draheim HJ; Kloppenburg P; Liss B; Striessnig J
    J Neurosci; 2017 Jul; 37(28):6761-6777. PubMed ID: 28592699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nilotinib inhibits microglia-mediated neuroinflammation to protect against dopaminergic neuronal death in Parkinson's disease models.
    Wu J; Xu X; Zheng L; Mo J; Jin X; Bao Y
    Int Immunopharmacol; 2021 Oct; 99():108025. PubMed ID: 34364303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.